Pathological changes in various organs in HLA-B*57:01 transgenic mice with abacavir-induced skin eruption
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Pathological changes in various organs in HLA-B*57:01 transgenic mice with abacavir-induced skin eruption ; day:6 ; month:1 ; year:2024 ; pages:1-13
Toxicological research ; (6.1.2024), 1-13
- Urheber
-
Kazaoka, Akira
Kumagai, Kazuyoshi
Matsushita, Junya
Aida, Tetsuo
Kuwahara, Saki
Aoki, Shigeki
Ito, Kousei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s43188-023-00220-1
- URN
-
urn:nbn:de:101:1-2024031921114791405563
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kazaoka, Akira
- Kumagai, Kazuyoshi
- Matsushita, Junya
- Aida, Tetsuo
- Kuwahara, Saki
- Aoki, Shigeki
- Ito, Kousei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Peptide binding specificities of HLA-B*5701 and B*5801
5701
5535-5701
5701. - 5750.
57.01. Jahresrechnungen
NW 57/01 - 07 NO 57/01 - 07
HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia
The molecular basis of differential immunological HLA-B*57:01-associated adverse drug reactions
Cost-effectiveness analysis of HLA-B*5701 screening in preventing abacavir hypersensitivity in Spain
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
HLA-B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity
I: Nr. 5701 - 9290
Peptide binding specificities of HLA-B*5701 and B*5801
5701
5535-5701
5701. - 5750.
57.01. Jahresrechnungen
NW 57/01 - 07 NO 57/01 - 07
HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia
The molecular basis of differential immunological HLA-B*57:01-associated adverse drug reactions
Cost-effectiveness analysis of HLA-B*5701 screening in preventing abacavir hypersensitivity in Spain
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
HLA-B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity
I: Nr. 5701 - 9290
Peptide binding specificities of HLA-B*5701 and B*5801
5701
5535-5701
5701. - 5750.
57.01. Jahresrechnungen
NW 57/01 - 07 NO 57/01 - 07
HLA-B*57:01 allele prevalence in treatment-Naïve HIV-infected patients from Colombia
The molecular basis of differential immunological HLA-B*57:01-associated adverse drug reactions
Cost-effectiveness analysis of HLA-B*5701 screening in preventing abacavir hypersensitivity in Spain
HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
HLA-B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity